CHGA stock forecast, quote, news & analysis

Key Takeaways

• CHGA shares have declined roughly 38% over the trailing 30 days, falling from about $3.49 to approximately $2.16.
• The drop extends a broader multi-month selloff, with the stock down roughly 70% over the trailing three months.
• A 1-for-20 reverse stock split in late August, undertaken to regain Nasdaq listing compliance, was followed by continued downward pressure.
• Dilutive financing activity in September, including promissory note issuances and an amended equity purchase agreement, has weighed on investor sentiment.
• Change Agents remains in an early, pre-revenue stage of its agentic AI transformation, with a modest market capitalization and limited liquidity.

Change Agents Corporation (CHGA) Company Overview and Market Position

Change Agents Corporation, formerly Avalon GloboCare Corp., is a Freehold, New Jersey-based technology company that rebranded in July 2026 as part of a strategic pivot into agentic artificial intelligence. The company operates through two segments: an artificial intelligence software segment built around Beacon, a Generative Engine Optimization platform designed to improve AI discoverability, and Catch-Up, an agentic AI-powered video content creation platform developed with the help of Caylent, an Amazon Web Services Premier Tier Services Partner. A consumer health technology segment distributes the KetoAir breathalyzer, an FDA-registered Class I device.

Change Agents has also signaled an intention to expand into AI-enabled autonomous air defense and counter-unmanned aircraft systems through a newly formed subsidiary. Investors follow the stock primarily for its AI transformation narrative, though the company is a small-cap, early-stage issuer with a limited employee base and little reported revenue to date.

Change Agents Corporation (CHGA) Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, CHGA has moved decisively lower. The stock traded near $3.49 in late August and has since declined to approximately $2.16, a decrease of about 38%. The move has been largely one-directional, with the shares grinding toward the lower end of their recent trading range.

The 30-day decline is part of a longer downtrend. Over the trailing quarter, the stock has fallen from roughly $7.12 in late June to its current level, representing a decline of approximately 70%. This sustained slide reflects both structural changes in the company's capital structure and persistent pressure on small-cap, pre-revenue AI issuers.

What Drove CHGA Stock Price in the Last 30 Days

The most significant event during the period was a 1-for-20 reverse stock split, which took effect in late August 2026. The split was implemented to raise the per-share price and regain compliance with Nasdaq's minimum $1.00 bid price requirement. While reverse splits mechanically increase the share price, they do not change a company's underlying fundamentals, and in this case the shares continued to face selling pressure in the weeks that followed.

Financing-related developments also contributed to the move. In early September, the company issued $280,000 in promissory notes with a 7% interest rate, alongside pre-funded warrants with a nominal exercise price, and amended an equity purchase agreement with an institutional investor to lower the per-share purchase price to $2.00. These transactions, reported in SEC filings, highlight ongoing funding needs and the potential for further dilution, which can pressure a thinly capitalized stock. With a market capitalization of only about $2.2 million and a low current ratio, concerns around liquidity and shareholder dilution have been central to the recent price action.

What Drove CHGA Stock Performance Over the Last Quarter

The quarterly decline reflects a broader corporate transformation. In July 2026, the company changed its name from Avalon GloboCare Corp. to Change Agents Corp. and shifted its ticker from ALBT to CHGA, positioning itself as a pure-play agentic AI software company. While the rebranding attracted attention, the company's AI products remain largely pre-revenue, with Beacon still approaching launch and Catch-Up in development.

Over the same period, the company moved to preserve its Nasdaq listing through the reverse split and continued to rely on dilutive capital raises to fund operations. The combination of an early-stage business model, minimal reported cash, and recurring equity-linked financings has kept the stock under sustained pressure, overshadowing the strategic AI narrative.

Trending AI Robots

Investors and traders looking for systematic approaches to markets may find value in Tickeron's Trending AI Robots page. Tickeron offers hundreds of AI trading bots that monitor thousands of tickers, but only the top-performing and most relevant bots are featured in this curated section. The bots vary widely in strategy, timeframe, and performance metrics, giving users a range of approaches to explore rather than a one-size-fits-all signal. The page is designed to help users discover active strategies and understand how AI-driven systems identify opportunities across different market conditions.

CHGA Stock Forecast Drivers: What Investors Should Watch Next

Several factors are likely to shape CHGA's trajectory in the coming months. The commercial launch of Beacon and the progress of the Catch-Up platform toward monetization will be important tests of the company's AI strategy. Investors should also monitor whether the company can generate meaningful recurring revenue and manage its cash position without relying on further dilutive financing. Nasdaq listing compliance remains a key consideration following the reverse split, and any additional capital raises, warrant exercises, or changes to the share structure could influence the stock. Broader sentiment toward small-cap and pre-revenue AI companies, as well as developments in the company's emerging defense and counter-drone initiatives, may also affect trading activity. These factors are presented for informational purposes and do not constitute a forecast of future performance.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations